Skip to main content
. 2024;13(2):120–132. doi: 10.22088/IJMCM.BUMS.13.2.120

Fig.1.

Fig.1

Anti-inflammation assessment of Losartan on murine macrophage RAW264.7 cell lines under LPS-induced inflammation, (A) Released nitric oxide (NO) was determined by Griess’s reagent. (B) Cell viability was assessed by MTT assay. (C) Intracellular ROS determination was done by H2DCFDA staining. Asterisk* was used to indicate significant data (p<0.05).LOS; Losartan, Diclo; Diclofenac, Un; untreated, ns; no significant